Atypical Femoral Fracture: 2015 Position Statement of the Korean Society for Bone and Mineral Research

Bisphosphonate (BP) is a useful anti-resorptive agent which decreases the risk of osteoporotic fracture by about 50%. However, recent evidences have shown its strong correlation with the occurrence of atypical femoral fracture (AFF). The longer the patient takes BP, the higher the risk of AFF. Also,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Kyu Hyun, Min, Byung Woo, Ha, Yong-Chan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society for Bone and Mineral Research 2015
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572036/
https://www.ncbi.nlm.nih.gov/pubmed/26389082
http://dx.doi.org/10.11005/jbm.2015.22.3.87

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572036/
https://www.ncbi.nlm.nih.gov/pubmed/26389082
http://dx.doi.org/10.11005/jbm.2015.22.3.87

Ejemplares similares